|
CDNA
|
CareDx, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
CARA
|
Cara Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
BTAI
|
BioXcel Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
BNGO
|
Bionano Genomics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
BLUE
|
bluebird bio, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
BLFS
|
BioLife Solutions, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
BBIO
|
BridgeBio Pharma, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
AXGN
|
AxoGen, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
AVXL
|
Anavex Life Sciences Corp.
|
0.01%
|
US
|
NASDAQ
|
|
AVEO
|
AVEO Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ATRI
|
ATRION Corporation
|
0.01%
|
US
|
NASDAQ
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ARCT
|
Arcturus Therapeutics Ltd.
|
0.01%
|
US
|
NASDAQ
|
|
ANIP
|
ANI Pharmaceuticals, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ANIK
|
Anika Therapeutics Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ANGO
|
AngioDynamics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ANAB
|
AnaptysBio, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ALLK
|
Allakos Inc.
|
0.01%
|
US
|
NASDAQ
|
|
ALEC
|
Alector, Inc.
|
0.01%
|
US
|
NASDAQ
|